We are live on
!
Find out more
Mariner Portfolio holdings
AUM
$85.7B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$60.1B
AUM Growth
+$549M
(+0.92%)
Cap. Flow
+$2.9B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
25.35%
Holding
3,637
New
259
Increased
1,894
Reduced
1,172
Closed
208
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$271M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$174M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$139M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$124M |
| 5 |
Progressive
PGR
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$247M |
| 2 |
Prudential Financial
PRU
|
+$113M |
| 3 |
Adobe
ADBE
|
+$107M |
| 4 |
Advanced Micro Devices
AMD
|
+$102M |
| 5 |
Textron
TXT
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.21% |
| 2 | Financials | 8.47% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.15% |
| 5 | Communication Services | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TAOX
3351
Tao Synergies Inc
TAOX
$24.6M
| $25K | ﹤0.01% |
+10,328
| New | +$31.4K |
|
3352
AbCellera Biologics
ABCL
$1.62B
| $24.5K | ﹤0.01% |
10,966
-3,574
| -25% | -$10.3K |
|
3353
Femasys
FEMY
$11.2M
| $24.5K | ﹤0.01% |
980
+43
| +5% | +$1.16K |
|
3354
Navitas Semiconductor
NVTS
$2.66B
| $24.4K | ﹤0.01% |
11,898
+72
| +0.6% | +$206 |
|
3355
ProQR Therapeutics
PRQR
$243M
| $24.4K | ﹤0.01% |
18,334
| – | – |
|
3356
Drilling Tools International
DTI
$81.2M
| $24K | ﹤0.01% |
10,123
-16,260
| -62% | -$50.3K |
|
|
MODV
3357
DELISTED
ModivCare
MODV
| $23.8K | ﹤0.01% |
18,089
+7,988
| +79% | +$38.6K |
|
|
NBP
3358
NovaBridge Biosciences American Depositary Shares
NBP
$205M
| $23.7K | ﹤0.01% |
28,760
| – | – |
|
3359
LiveOne
LVO
$66M
| $23.7K | ﹤0.01% |
3,387
-836
| -20% | -$8.23K |
|
3360
Nkarta
NKTX
$162M
| $23.7K | ﹤0.01% |
12,861
+475
| +4% | +$974 |
|
3361
Alpha Tau Medical Warrant
DRTSW
$74.4M
| $22.3K | ﹤0.01% |
93,888
| – | – |
|
3362
Generation Income Properties
GIPR
$671K
| $21.6K | ﹤0.01% |
+1,352
| New | +$23K |
|
3363
Compass Therapeutics
CMPX
$373M
| $21.6K | ﹤0.01% |
11,381
-9,292
| -45% | -$24.7K |
|
|
NOVA
3364
DELISTED
Sunnova Energy
NOVA
| $21.4K | ﹤0.01% |
57,474
-77,305
| -57% | -$149K |
|
3365
Twin Vee PowerCats
VEEE
$7.41M
| $21.4K | ﹤0.01% |
173
| – | – |
|
|
CLYM
3366
Climb Bio
CLYM
$735M
| $21K | ﹤0.01% |
17,187
-81,102
| -83% | -$132K |
|
3367
Inovio Pharmaceuticals
INO
$79.8M
| $21K | ﹤0.01% |
+12,856
| New | +$25.8K |
|
3368
Trio Petroleum
TPET
$13M
| $20.7K | ﹤0.01% |
+15,000
| New | +$23.5K |
|
3369
iPower
IPW
$1.27M
| $20.4K | ﹤0.01% |
170
| – | – |
|
3370
ChargePoint
CHPT
$133M
| $20.4K | ﹤0.01% |
1,683
+1,083
| +181% | +$18.1K |
|
3371
Clean Energy Fuels
CLNE
$447M
| $20.3K | ﹤0.01% |
13,088
-11,824
| -47% | -$30K |
|
3372
TScan Therapeutics
TCRX
$51.9M
| $20.1K | ﹤0.01% |
+14,580
| New | +$31.5K |
|
3373
Pacific Biosciences
PACB
$422M
| $19.9K | ﹤0.01% |
16,857
-12,907
| -43% | -$19.8K |
|
|
VTYX
3374
DELISTED
Ventyx Biosciences
VTYX
| $19.4K | ﹤0.01% |
16,855
-5,250
| -24% | -$9.01K |
|
3375
Black Diamond Therapeutics
BDTX
$101M
| $18.5K | ﹤0.01% |
+11,911
| New | +$25K |
|
Similar funds
Mariner's Q1 2025 Portfolio in Review
As of Q1 2025, Mariner held 3,637 positions worth $60.1B, up 0.92% from $59.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Mariner deployed $2.9B of net new capital in Q1 2025, opening 259 new positions and adding to 1,894 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 512,742 shares worth $13.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Tesla, an estimated $247M trimmed.
- Mariner's largest Q1 2025 buy was VanEck IG Floating Rate ETF: 512,742 shares worth $13.1M.
- Mariner added most to Apollo Global Management in Q1 2025, an estimated $271M increase.
- Mariner's biggest Q1 2025 reduction was Tesla, cutting an estimated $247M.
- Mariner fully exited CrossFirst Bankshares, Inc. Common Stock in Q1 2025, selling an estimated $4.6M.
- Mariner's ten largest holdings make up 25% of its $60.1B portfolio in Q1 2025.
- Mariner opened 259 new positions and closed 208 in Q1 2025.
- Mariner's portfolio value rose 0.92% quarter-over-quarter to $60.1B.
Based on Mariner's 13F filing for Q1 2025, filed 15 May 2025.